This multicentre audit reviewed the records of 431 patients who had undergone major elective surgery. The authors sought to determine how well IV fluids were prescribed both intraoperatively and perioperatively when compared with current guidance. On the positive side, they found that patients were allowed oral fluids early; however, there was huge variation in the volume of fluid given intraoperatively, an excess of sodium and fluid overall often being given postoperatively, and potassium supplementation was inadequate.
The fundamental goal of fluid management is to maintain the fluid distribution and electrolyte balance of a patient where their own systems are unable to do so. In the surgical setting, both inadequate and excessive fluid therapy have been linked with poorer outcomes; this has led to increased emphasis on optimal fluid management, and guidelines have emerged highlighting areas of risk. Despite this recognition, the evidence base surrounding perioperative fluid management remains inconsistent. Compounding this are entrenched attitudes to practice, as well as recognition that deviations from accepted practice are appropriate at times. Several studies have suggested that despite the guidelines, prescribing remains suboptimal. The basis of this study was to determine to what extent practice adhered to the guidance.
This audit was carried out across five hospitals in southern England, and the intention was to analyse the notes of 100 patients per hospital, and 150 in the largest centre. In practice, not all of the notes were available, resulting in 431 of 550 cases being reviewed. The population was adults undergoing elective surgery. Minor procedures, procedures performed under regional anaesthetic, and day-case surgeries were excluded. To minimise bias, the first 100 eligible patients for each year were included. Demographic information including weight, age and operation type were collected, as was information on the type of fluid administered and the quantities of electrolytes. Fluid balance was calculated from input/output charts, and serum electrolyte measurement was reviewed where available. Data were reviewed until day 3 post-op, the day after IV fluids were ceased, or the day of discharge – whichever occurred first.
Of the cases reviewed, 43% were orthopaedic, 23.5% were upper gastrointestinal (GI), the remaining 33.5% were lower GI, gynaecological or urological. The most common fluids prescribed were balanced crystalloids, particularly in the intraoperative period, while dextrose saline and 0.9% saline began to increase in use postoperatively. Nearly all patients received some fluid intraoperatively, with the most common procedures being laparoscopic right hemicolectomy, total hip replacement and total knee replacement. There was marked variation in the intraoperative volume of fluid given, that was not linked to bodyweight. Postoperatively, around 50% received IV fluids on day 1, dropping to around 25% on day 2 – there was no correlation between bodyweight and volume administered. For those patients on IV fluids on day 1, around half the patients received excess sodium and water, while almost all received less than maintenance potassium. The incidence of hyponatraemia increased progressively after surgery, and was most marked in those given dextrose saline. The incidence of hypokalaemia also increased progressively; 4% were hypokalaemic on day 1, 6% on day 2 and 10% on day 3, up from 1.5% preoperatively.
The authors point to the drop off in patients on IV fluids as evidence that enhanced recovery principles were being followed – allowing early oral fluids. In those patients continuing on fluids, electrolyte disturbances became increasingly common, and replacement was not being optimised. They also note the variation in volumes received intraoperatively as a reflection of erratic application of guidance.
Strengths of the study were:
Suggestions to improve the way fluids are prescribed included education – particularly for more junior doctors, as ward-based prescribing and awareness of electrolyte imbalance was not done effectively, and hypokalaemia is linked to a prolonged recovery. The observed hyponatraemia was most likely due to the physiological injury due to surgery, but there may be an effect from dextrose saline.
This study provides an important snapshot of how fluid is being prescribed, and shows it to be sub-optimal in practice. The authors emphasise the need for regular audit cycles to examine how well any centre adheres to best practice. This study is particularly important as it provides a much greater context for how patients are managed, including data examining the ward-based setting – data collection has typically been based off anaesthetic charts, which give a more easily quantified, yet more limited view of practice.
Catch-up on the debate surrounding hydroxyethyl starch use as we take you on an interactive journey through its changing fortunes. Do you think current restrictions will be enough to change clinical practice?
This position paper from the Italian Association for the Study of the Liver (AISF) and the Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) reviews the evidence for the use of albumin in several settings related to liver cirrhosis.
This paper presents a meta-analysis to determine the impact of resuscitation with albumin on the morbidity and mortality of adult burn patients.
This meta-analysis examines whether the dosing of albumin affects outcomes in type 1 hepatorenal syndrome (HRS).
This review article explores the relationship between low albumin levels and acute kidney injury (AKI).
This meta-analysis pooled data from three large randomised controlled trials to determine whether early goal-directed therapy (EGDT) was an effective intervention for managing septic shock.
This systematic review and meta-analysis looked at the different mortality rates of various intravenous fluids and fluid protocols when used for resuscitation in sepsis.
This Chinese randomised controlled study explores the impact that a goal-directed fluid restriction (GDFR) protocol had on outcomes during anaesthesia for brain surgery.
This review paper examines the role of albumin in chronic liver disease, assessing the evidence for its use in several key clinical areas.
This matched cohort study aimed to determine whether a goal-directed fluid therapy (GDFT) intervention, delivered intraoperatively, would reduce post-operative morbidity in patients undergoing hip revision surgery.
This study explored fluid prescribing practices in intensive care – providing a picture of how fluid resuscitation is being managed internationally.
This multicentre audit reviewed the records of 431 patients who had undergone major elective surgery. The authors sought to determine how well IV fluids were prescribed both intraoperatively and perioperatively when compared with current guidance.
This double-blinded, randomised controlled trial examined whether pre-operative administration of exogenous albumin affected rates of acute kidney injury (AKI).
This article is a review and summary of the current opinion of albumin in fluid management.
This retrospective, observational study used a propensity scoring system to match patients treated with saline with those given a balanced, calcium-free fluid.
A recent PRAC review has recommended suspension of marketing authorisations for HES solutions for infusion across the EU.
Following the European Medicines Agency’s (EMA) suspension of the marketing authorisations of hydroxyethyl starch (HES) solutions across the European Union (EMA, 2018), Roberts et al., have written an open letter addressed to the World Health Organization (WHO) Director General seeking support for the suspension of HES solutions and expanding it to a worldwide ban.
The Coordination Group for Mutual Recognition and Decentralised Procedures (CMDh) endorse the suspension of hydroxyethyl-starch (HES) solutions, due to serious risks of kidney injury and death in certain patient populations.
The hypothesis that hypertonic fluid has a dual physiological role, increasing circulatory volume while administering minimal volumes and muting the pro-inflammatory response to injury and illness, may be appealing, but is it superior to isotonic fluids in practice?
In this post-hoc, subgroup analysis (study 1) and prospective, single-centre nested cohort (study 2) from the SPLIT (0.9% saline vs. PL-148 for ICU fluid therapy) trial, the investigators hypothesised that patients receiving Plasma-Lyte 148 would require fewer blood products and have less post-operative bleeding than those receiving saline.
Acute kidney injury (AKI) affects one-fifth of major surgery patients, increasing the risk of long-term mortality. This review paper discusses recent study data, discussing the best methods for preventing postoperative AKI.
Guidelines to promote the early recovery of patients undergoing major surgery recommend a restrictive intravenous-fluid strategy for abdominal surgery. However, the supporting evidence is limited, and there is concern about impaired organ perfusion.
Cirrhosis of the liver is a leading cause of mortality. For patients with decompensated cirrhosis, long-term weekly human albumin administration can act as an effective disease-modifying treatment.
In 1896 Ernest Starling published his hypothesis for fluid exchange, whereby fluid exchange exists mainly in the capillaries through a process of plasma ultrafiltration across semipermeable membranes (Starling, 1896). But is this 19th century theory something of the past?
Long-term albumin treatment for ascites associated with cirrhosis has been debated in recent years, with mixed results reported for the treatment’s efficacy. In this non-randomised prospective study, Di Pascoli and colleagues question the benefits of long-term albumin in patients with liver cirrhosis and refractory ascites, focussing on survival and emergent hospitalisations. Could this be part of the solution to the ongoing challenge of ascites in cirrhosis?
The choice of fluid administered during cardiac surgery remains a debated topic, often focussed around colloid solutions containing albumin. Conflicting results from numerous studies have left questions over albumin safety and potential to be superior to crystalloids during surgery. Kingeter et al. hoped to achieve clarity on this controversial topic in a retrospective study of cardiac surgery outcomes over a 12-year period.
Patients admitted to intensive care are often haemodynamically unstable with fluid resuscitation therapy regularly used to overcome this. The use of small volume resuscitation with 20% albumin has historically been limited compared to standard fluid resuscitation with 4–5% albumin due to safety concerns, but could those concerns be misplaced? Read more about how the SWIPE trial has provided new insights into the possibilities of using small volume resuscitation within the ICU.